TGT Update, Fresh Options Idea

Target Corp. TGT

Just as we mentioned yesterday morning to start off the week, it was on Thursday morning that we signaled our interest in tracking some TGT Puts. They hadn’t quite heated up yet by the end of last week, but we urged readers yesterday to pay close attention, as the gains seemed imminent.

We were correct in that assumption, as the markets once again set a new record for worst daily losses in history. That helped propel the massive range of contracts we signaled, the TGT 04/03 $98-90 Puts, to double-bag gain status and beyond, exactly as we predicted.

Here are the trading ranges on those contracts since we’ve had them on our radar:

TGT 04/03 $98-90 Puts
$98: 3.37-6.92 (+105%)
$97: 2.90-6.60 (+128%)
$96: 2.73-6.00 (+120%)
$95: 2.21-5.95 (+169%)
$94: 2.54-5.50 (+117%)
$93: 1.99-5.05 (+154%)
$92: 2.44-4.50 (+84%)
$91: 2.00-4.25 (+113%)
$90: 1.47-3.80 (+156%)


Transdigm Group, Inc TDG

We would like to put together a set of call contracts to watch in the TDG chain. It’s no surprise that the stock is at a bottom at present, but what is remarkable is the amount of insider buying that has taken place in the last week, to the tune of roughly $180M.

That typically signals an insider’s confidence that the stock will not fall much further. We are going to put the TDG 05/15 $350-370 Calls on watch to track in the weeks ahead.


Extended Watchlist:
CODX, AYTU, IBIO, MBRX, APT, SPCE, TOMDF

Blue Horseshoe Stocks: NUGN Recap, New Watchlist & More

NuGene International, Inc. NUGN

We entered NUGN into the mix on Friday as one to put on bottom-watch, and it instantly became the latest in a string of perfectly timed rebound plays. After taking an absolute beating during Thursday’s session, wherein the PPS decreased by roughly 40%, the stock displayed an absolute turnaround.

From its open at 2.65, NUGN made a very respectable 26% intraday move on relatively heavy volume, hitting 3.33 shortly after noon. It maintained the majority of those gains into the close (3.10), so we’ll be on the lookout for possible momentum carryover.

We’ve identified some of the key aspects of the NUGN chart here:


Adding to Our Radar:

We’ve got a few stocks we want to put on a speculative watch for various reasons as we kick things off this week:

Axion Power International, Inc. AXPW – This fresh news play is the first that we want to enter as a possible new item of interest. The stock is trading massive premarket volume as the company published an interesting PR this morning. Take a look>> READ PR  

Trucept, Inc. TREP – This is a thinly-traded subpenny stock that is unusual due to its revenue-producing status. The company published its Q1 2015 financials this morning, so we want to tag this play for observation. An influx of volume could send TREP on a ride.

Indo Global Exchanges Pte Ltd. IGEX – This is a super-sub-penny momentum play for which we’ll want to reserve a spot on our watchlists. It’s began to trade up off of a relative bottom on Friday so we’ll be on the lookout for the possibility of some of that activity to spilling over into this week.

Enertopia Corp. ENRT – This is a stock that has been the subject of recent promotion. We’ve never mentioned it ourselves, but we want to put it on the radar today as it is coming off of quite a thrashing on Friday. There’s a chance it could present itself as a rebound play upon finding support.


Extended Watchlist:
NURO, PTBI, BLRX, IDRA, APT, AMDA, HQCL

Blue Horseshoe Stocks: APT, VTAE, NEWC & More

Alpha Pro Tech Ltd. APT 

Here’s a past gainer that began to catch our attention yesterday- We jumped on APT for the first time back on October 10th, while the stock was in the middle of a huge run. We observed the low of 5.72 on that day, and the stock took just two more sessions to reach a high of 10.73, marking a move of 87%

Following that big spike, APT had been beaten back over the past couple weeks, and this week, has begun to bounce off support above the 50DMA (3.58). We want to pay attention as the stock attempts a recovery.


Vitae Pharma, Inc. VTAE

We want to put VTAE on our radar as we close out the week, and keep an eye on it moving forward. The stock is gapping up big this morning; it had already been on the incline prior to yesterday’s news that really served to heat things up.

VTAE announced it had received positive results from a couple of its Phase-1 trials for an Alzheimer’s treatment they claim “Demonstrated Greater Than 80% Reduction of an Alzheimer’s Disease Biomarker” >> VIEW PR

The statement indicated that the results would lead to further trials over the next several months, so we’re going to enter VTAE into the log and reserve it a spot on our watchlists.


New Columbia Resources, Inc. NEWC

NEWC is a play we want to radar and add to our expansive marijuana-stock watchlist. We’re always keeping our eyes peeled for new cannabis stocks to watch, and we caught this one on a news scan today.

The company announced that its “Colombian subsidiary, Sannabis S.A.S., has legally produced  a trial run of cannabis based products on an Indian reservation.”


Infinera Corp. INFN

INFN appeared in yesterday’s report and made a decent move on strong volume, to the tune of nearly 10X the monthly average. The stock traded in a range from 12.17-13.96, a 15% intraday increase. We’ll be keeping watch over this play into next week as well.


Extended Watchlist:
OMEX, HEB, RUBI, IBIO

Blue Horseshoe Stocks: VSR, IBIO & More

Versar, Inc. VSR

VSR continued to play the role of this week’s most interesting pick on Thursday. The action in this play has been significant, and it has led to several potentially profitable swings since we first picked it up on Tuesday at a low of 3.70.

Yesterday we re-iterated our interest, stating that the kind of volatility we had seen in VSR to that point could certainly lead to further bounce opportunities, and we were correct in that assumption. In early trading, we witnessed a swing from 6.56 to the daily high of 7.817, a 19% move. We then watched as VSR spent a good portion of the afternoon in pullback mode before bouncing off of support at in the 5.20’s.

The stock is up in premarket trading again today with highs of over $6 so far, so for the fourth straight day we’ll have our eye on possible bounce action from VSR


Eagle Bulk Shipping EGLE

We tagged EGLE yesterday morning on the heels of a financial restructuring that led to a serious boost in PPS. The stock was up so much in fact, it was briefly halted early in the session. When trading resumed at 11AM, the stock still went on to make one heck of a move.

From an initial low of 12.02, the EGLE barreled its way up to a high of 17.00, a solid 41% increase on the day on significantly high volume.


iBio, Inc. IBIO

IBIO is a play that we’ve been tracking for some time, and it too posted a notable swing yesterday afternoon, as it rose up from 1.63 to touch 1.93, an 18% increase. The stock is also gapping up in the premarket this morning, having re-breached the $2-mark.


Repros Therapeutics, Inc. RPRX

This is a stock we caught this morning, noticing that it is gapping down 52-week lows in the pre-market. The company had some negatively received FDA news this morning. This kicks in our ‘vulture’ mindset, where we monitor a struggling play for signs of a turnaround and subsequent bounce. We can’t even begin to recall how many times we’ve turned a beaten-down stock into a winning trade on the rebound but rest assured, its enough for us to keep a close watch over RPRX moving forward.


Extended Watchlist:
APT, CYTR, ESI, AKS

Blue Horseshoe Stocks: A Word on Ebola & Much More

A Word on the “Ebola Effect”

In a hype-filled environment that is beginning to resemble early-2014’s cannabis “green rush”, most stocks with news announcements even remotely connected to the Ebola virus have been seeing exponential spikes in activity. Fear, no matter how irrational, can be one of the market’s most potent driving forces, and we are seeing affirmations of this left and right. Regardless of the cause or rationale, we are always standing at the ready to take advantage of powerful trends, and so far we’ve done a pretty good job of tracking down some Ebola-related winners in the last couple of weeks.. There were two in yesterday’s report alone.

NanoLogix, Inc. NNLX

NNLX was a standout which announced yesterday morning that it was “configuring its N-Assay Rapid diagnostic kits for both Ebola Virus and Enterovirus detection”  and as a result, the stock leaped out of the gate to make a serious move first thing in the morning. It traded in a massive range, running rapidly from .06 to .18;  a full 200% intraday move!

  Aethlon Medical, Inc. AEMD

AEMD was another one we were tracking from yesterday’s newsletter, and the company subsequently published a report stating that it had used its “Hemopurifier” to treat an Ebola patient in Sierra Leone. It led to a 37% intraday swing (.19-26).

New Entry on Our Ebola Watchlist:

We’re also going to radar WholeHealth Products, Inc. GWPC after we caught an after-hours PR yesterday evening. With untraded-upon news on such a hot topic, we’ll be anxious to see how the stock responds today.


Accentia BioPharmaceticals, Inc.  ABPI

While not an Ebola-connected biopharma play, were glad to have included ABPI in yesterday’s premarket report. Its SinuNase sinusitis treatment has been fast-tracked by the FDA, and the company happened to release word that “several unnamed pharmaceutical companies… have approached the company over SinuNase.”

The announcement caused a monstrous spike in early trading with stock jumping up from the open at .0065 and reaching .027! That works out to a mammoth move of 315% and there was also a subsequent dip-and-rip as the stock came off that initial high. It bounced off of a penny and ran back to .023, adding a 130% swing, and that was followed by yet another from .0107 to .018 (+68%).

In total, we witnessed 513% in cumulative gains for the day, so congrats to anyone who caught our tag, because even if you only took advantage of a fraction of those intraday moves, chances are you still walked away with a tidy profit.


ChinaNet Online Holdings, Inc. CNET

We’ve been tracking CNET pretty closely since we first caught it on a momentum scan back on Sept. 22nd, and re-tagged it in yesterday’s report. Following some news, we saw a couple of respectable intraday swings out of the stock. First, from 1.55 to 2.17 (+40%), and then again from 1.83 to 2.16 (+18%).

The company announced it was teaming with credit search engine Haodai and the Yooli crowdfunding outfit to offer “Zero Down Payment Loans” to entrepreneurs. >>View PR


Extended Watchlist:
APT, VSR, PPHM, RCPI, IBIO,

Get Our FREE Daily Reports!